deltatrials
Completed NA INTERVENTIONAL 2-arm NCT04837898

Haskap and Endurance Running Performance

The Influence of Haskap Berry on Exercise Performance

Sponsor: Haskapa Ltd

Interventions Haskapa Placebo
Updated 5 times since 2021 Last updated: Apr 5, 2022 Started: Apr 12, 2021 Primary completion: Nov 8, 2021 Completion: Dec 8, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04837898, this NA trial focuses on Exercise Performance and remains completed. Sponsored by Haskapa Ltd, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~May 2021 – ~May 2022 · 12 months · monthly snapshotNot Yet Recruiting~May 2022 – ~Jul 2024 · 26 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. May 2022 — Jul 2024 [monthly]

    Completed NA

    Status: Not Yet RecruitingCompleted

  5. May 2021 — May 2022 [monthly]

    Not Yet Recruiting NA

    First recorded

Apr 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Haskapa Ltd
  • Mibelle Group Biochemistry
  • Northumbria University
Data source: Northumbria University

For direct contact, visit the study record on ClinicalTrials.gov .